These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29274117)

  • 1. Sarcoid-like granulomatosis in a patient receiving anti-TNFα for psoriasis.
    Leventaki V; Flerlage J
    Am J Hematol; 2018 May; 93(5):722-723. PubMed ID: 29274117
    [No Abstract]   [Full Text] [Related]  

  • 2. Necrotizing Granulomas in a Patient With Psoriasis and Sarcoidosis After Adalimumab-Medication-Induced Reaction or Reactivation of Latent Disease?
    Turkowski Y; Konnikov N; Mahalingam M
    Am J Dermatopathol; 2019 Sep; 41(9):661-666. PubMed ID: 30839343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal sarcoid-like granulomatosis during anti-TNF therapy.
    Villemaire M; Cartier JC; Mathieu N; Maurizi J; Pinel N; Bonaz B; Zaoui P; Carron PL
    Kidney Int; 2014 Jul; 86(1):215. PubMed ID: 24978390
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic sarcoidosis reactions as a result of tumour necrosis factor-alpha treatment for patients with psoriasis.
    Bewley AP; Maleki S
    Clin Exp Dermatol; 2021 Dec; 46(8):1548-1550. PubMed ID: 34021925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necrotizing Sarcoid Granulomatosis: Clinico-Radio-Pathologic Diagnosis.
    McArdle DJT; McArdle JP; Jessup P; Harle RA; Parker S
    Am J Med; 2017 Jul; 130(7):e283-e286. PubMed ID: 28389312
    [No Abstract]   [Full Text] [Related]  

  • 6. Necrotizing sarcoid-like granulomatosis: radiologic-pathologic correlation.
    Fisher MR; Christ ML; Bernstein JR
    J Can Assoc Radiol; 1984 Sep; 35(3):313-5. PubMed ID: 6501390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of Autoantibodies and Autoimmune Diseases in Patients with Psoriasis Receiving Tumor Necrosis Factor Inhibitors.
    Oter-López B; Llamas-Velasco M; Sánchez-Pérez J; Dauden E
    Actas Dermosifiliogr; 2017 Jun; 108(5):445-456. PubMed ID: 28267955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tender facial nodules in a man receiving adalimumab for psoriasis.
    Kreeshan FC; Jamieson LA; Griffiths CEM
    Clin Exp Dermatol; 2022 Jan; 47(1):202-205. PubMed ID: 34437728
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-TNF-α for necrotizing sarcoid granulomatosis of the liver.
    Sebode M; Weidemann S; Wehmeyer M; Lohse AW; Schramm C
    Hepatology; 2017 Apr; 65(4):1410-1412. PubMed ID: 27981598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated tuberculosis following adalimumab treatment in psoriasis despite negative screening.
    Bae JY; Lee JI; Kim HL; Suh HY; Jung HJ; Park MY; Youn JI; Ahn JY
    Int J Dermatol; 2019 Jan; 58(1):98-100. PubMed ID: 29845601
    [No Abstract]   [Full Text] [Related]  

  • 11. Mucosal leishmaniasis mimicking T-cell lymphoma in a patient receiving monoclonal antibody against TNFα.
    Nicodemo AC; Duailibi DF; Feriani D; Duarte MIS; Amato VS
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005807. PubMed ID: 28934199
    [No Abstract]   [Full Text] [Related]  

  • 12. Orbital Sarcoid-Like Granulomatosis After Inhibition of Tumor Necrosis Factor-α.
    Wladis EJ; Tarasen AJ; Roth ZJ; Farber MG; Ross J; Michaels VM
    Ophthalmic Plast Reconstr Surg; 2016; 32(2):e30-2. PubMed ID: 24841734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium marinum infection contracted from seaweed wrap in a psoriasis patient undergoing treatment with adalimumab.
    Timoney I; Lynch M; Timoney L; Feeney E; Kirby B
    Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis.
    Gibellini L; De Biasi S; Bianchini E; Bartolomeo R; Fabiano A; Manfredini M; Ferrari F; Albertini G; Trenti T; Nasi M; Pinti M; Iannone A; Salvarani C; Cossarizza A; Pellacani G
    PLoS One; 2016; 11(12):e0167757. PubMed ID: 27936119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the TNF-α inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET.
    Milman N; Graudal N; Loft A; Mortensen J; Larsen J; Baslund B
    Clin Respir J; 2012 Oct; 6(4):238-47. PubMed ID: 22128762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophilia--A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis.
    Chiriac A; Brzezinski P; Stolnicu S; Podoleanu C; Moldovan C; Molnar C; Taranu T
    J Dermatolog Treat; 2016; 27(2):110-3. PubMed ID: 26292921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical case effects of psoriasis following adalimumab therapy: A case series.
    Zangrilli A; Bavetta M; Mazzilli S; Garofalo V; Bianchi L
    Dermatol Ther; 2018 Nov; 31(6):e12729. PubMed ID: 30239070
    [No Abstract]   [Full Text] [Related]  

  • 18. Adalimumab for treating childhood plaque psoriasis: a clinical trial evaluation.
    Di Lernia V
    Expert Opin Biol Ther; 2017 Dec; 17(12):1553-1556. PubMed ID: 28829204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of cyclosporine and anti-tumor necrosis factor α in psoriasis: a case series of 10 patients.
    Cohen Barak E; Kerner M; Rozenman D; Ziv M
    Dermatol Ther; 2015; 28(3):126-30. PubMed ID: 25640261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adalimumab Induced Subcutaneous Nodular Sarcoidosis; A Rare Side Effect of Tumor Necrosis Factor-α Inhibitor.
    Au S; Mirsaeidi M; Aronson IK; Sweiss NJ
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Oct; 31(3):249-51. PubMed ID: 25363227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.